Clinical trial
131-I-TM-601 Study in Adults With Solid Tumors
NCT00379132 · TransMolecular, Industry · Completed
Key facts
| NCT number | NCT00379132 |
|---|---|
| Title | 131-I-TM-601 Study in Adults With Solid Tumors |
| Official title | A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labeled Chlorotoxin in Patients With Recurrent or Refractory Somatic and/or Cerebral Metastatic Solid Tumors |
| Lead sponsor | TransMolecular, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer, Non-Small Cell Lung Cancer, Melanoma, Colorectal Cancer, Pancreatic Cancer, Prostate Adenocarcinoma, Glioma, Primary Solid Tumors |
| Intervention type | Drug |
| Interventions | 131-I-TM-601 (chlorotoxin) |
| Enrollment | 60 |
| Start date | Aug 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Sep 21, 2006 |
| Last update posted | Mar 31, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: